FIELD: medicine, pharmaceutics.
SUBSTANCE: bifidobacterial and lactobacillary consortium contains Bifidobacterium bifidum OV-19, B.bifidum 791, B.longum B379M, B.breve OV-12, B.infantis 73-15, Lactobacillus helveticus "К3ш24", L.helveticus NK-11, L.casei KHM-12; it is used for preparing bacterial preparations, as a part of dietary supplements for correcting the microflora in the children under the age of three. The consortium is high-technology; it stores a biomass on nutrient mediums over a short period of time with a high concentration of probiotic microorganisms, possesses the acid-forming and antagonist properties in relation to the pathogenic and opportunistic microflora. The consortium is prepared by the co-culture of the strains including the length of an exponential growth phase of each of them. Thereby a priority of the nutrient medium inoculation of the specific composition is determined.
EFFECT: using the consortium as a part of the bacterial preparation for treating the dysbiotic gastrointestinal conditions in the children, and the dietary supplements, provides the more effective and fast correction of the child's gastrointestinal microflora.
4 cl, 10 tbl, 3 ex
Authors
Dates
2013-08-27—Published
2012-05-14—Filed